Clinical Trials Logo

Clinical Trial Summary

The study will evaluate the efficacy of alpha-lipoic acid(α-LA) on mortality in patients with ischemic heart failure (NYHA Class II - IV and EF =< 45%).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03491969
Study type Interventional
Source Shanghai Zhongshan Hospital
Contact
Status Not yet recruiting
Phase Phase 4
Start date May 1, 2018
Completion date April 30, 2022

See also
  Status Clinical Trial Phase
Terminated NCT02240940 - PARACHUTE China Approval Trial N/A
Completed NCT00846001 - Resynchronization Surgery Combined Unified Efficacy Phase 3
Active, not recruiting NCT01961726 - Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure Phase 1/Phase 2
Terminated NCT00102128 - Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack. Phase 2
Recruiting NCT01555320 - Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure N/A
Recruiting NCT02875639 - A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome) Phase 2
Active, not recruiting NCT02700880 - LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry N/A
Active, not recruiting NCT01643590 - Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure. Phase 2
Active, not recruiting NCT02115568 - Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203 N/A
Recruiting NCT03206593 - Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure N/A
Enrolling by invitation NCT01709279 - Clinical Trial of Autologous Adipose Tissue Derived Stromal Cell Therapy for Ischemic Heart Failure N/A